Capital One, Others Provide Theragenics Facility
Capital One Bank, acting as administrative agent, with Credit Suisse Loan Funding LLC, as lead arranger and arranger agent, and Garrison Investment Group, announced the successful closing and funding of a $53.5 million, five-year senior secured credit facility for Theragenics Corp. in the fourth quarter of 2013.
Juniper Investment acquired Theragenics in October 2013, and the loan was used to finance a portion of the acquisition and to provide ongoing working capital.
“Capital One Bank is pleased to work with Theragenics, a proven market leader providing tremendous value to the industry, and to support the company’s growth strategy,” said Keith Reuben, SVP, Commercial and Specialty Finance, Capital One Bank. “Theragenics has an exciting future ahead and we are pleased to help position the company for continued market leadership and success.”
“The Juniper acquisition positions our company to continue serving the needs of our customers without the burden of public company costs,” said Frank Tarallo, CEO, Theragenics Corp. “We look forward to this exciting next stage in our company’s growth trajectory as we continue to provide outstanding value to our customers and build upon our strong foundation of quality, dedication and service. Capital One Bank played a critical role by supporting the financing solution needed to complete this deal.”
Theragenics is a medical device company serving the surgical products and prostate cancer treatment markets.